Literature DB >> 12499182

Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin.

P Cottagnoud1, M Cottagnoud, M G Täuber.   

Abstract

Vancomycin and gentamicin act synergistically against penicillin-resistant pneumococci in vitro and in experimental rabbit meningitis. The aim of the present study was to investigate the underlying mechanism of this synergism. The intracellular concentration of gentamicin was measured by using the following experimental setting. Bacterial cultures were incubated with either gentamicin alone or gentamicin plus vancomycin for a short period (15 min). The gentamicin concentration was determined before and after grinding of the cultures by using the COBAS INTEGRA fluorescence polarization system (Roche). The grinding efficacies ranged between 44 and 54%, as determined by viable cell counts. In the combination regimen the intracellular concentration of gentamicin increased to 186% compared to that achieved with gentamicin monotherapy. These data suggest that the synergy observed in vivo and in vitro is based on an increased intracellular penetration of the aminoglycoside, probably due to the effect of vancomycin on the permeability of the cell wall.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12499182      PMCID: PMC148974          DOI: 10.1128/AAC.47.1.144-147.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.

Authors:  P Cottagnoud; F Acosta; M Cottagnoud; K Neftel; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.

Authors:  D Rodoni; F Hänni; C M Gerber; M Cottagnoud; K Neftel; M G Täuber; P Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  Quantification of the antigen-antibody reaction by the polarization of fluorescence.

Authors:  W B DANDLIKER; G A FEIGEN
Journal:  Biochem Biophys Res Commun       Date:  1961-07-26       Impact factor: 3.575

4.  Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.

Authors:  M Perrig; F Acosta; M Cottagnoud; C M Gerber; M G Täuber; P Cottagnoud
Journal:  J Antimicrob Chemother       Date:  2001-05       Impact factor: 5.790

5.  Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.

Authors:  Philippe Cottagnoud; Cynthia M Gerber; Marianne Cottagnoud; Martin G Täuber
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

6.  Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities.

Authors:  D P Nicolau; P R Tessier; R Quintiliani; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

7.  Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci.

Authors:  R C Moellering; A N Weinberg
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

8.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

Review 9.  Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

Authors:  S L Kaplan; E O Mason
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

10.  Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae.

Authors:  P Cottagnoud; J M Entenza; M Cottagnoud; Y A Que; P Moreillon; M G Taüber
Journal:  BMC Microbiol       Date:  2001-07-02       Impact factor: 3.605

View more
  15 in total

1.  Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides.

Authors:  Aparna Anantharaman; Meryam Sardar Rizvi; Dinkar Sahal
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance.

Authors:  Svetolik Djurkovic; Jutta M Loeffler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Preincubation of pneumococci with beta-lactams alone or combined with levofloxacin prevents quinolone-induced resistance without increasing intracellular levels of levofloxacin.

Authors:  Philippe Cottagnoud; Maggie Johnson; Marianne Cottagnoud; Laura Piddock
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 4.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

5.  Treatment of Drug-resistant Pneumococcal Meningitis.

Authors:  Nida Hameed; Allan R Tunkel
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

Review 6.  [Local antibiotic therapy].

Authors:  Klaus-Dieter Kühn; Nora Renz; Andrej Trampuz
Journal:  Unfallchirurg       Date:  2017-07       Impact factor: 1.000

7.  7,10-Epoxyoctadeca-7,9-dienoic Acid: A Small Molecule Adjuvant That Potentiates β-Lactam Antibiotics Against Multidrug-Resistant Staphylococcus aureus.

Authors:  Chakradhar Dasagrandhi; Young-Soon Kim; In-Hwan Kim; Ching T Hou; Hak-Ryul Kim
Journal:  Indian J Microbiol       Date:  2017-10-09       Impact factor: 2.461

8.  Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein.

Authors:  Huayong Liu; Dan Zhao; Jun Chang; Liang Yan; Fuju Zhao; Youcong Wu; Tao Xu; Ting Gong; Li Chen; Nianan He; Yang Wu; Shiqing Han; Di Qu
Journal:  Appl Microbiol Biotechnol       Date:  2014-04-17       Impact factor: 4.813

9.  Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET.

Authors:  Laura R Marks; Emily A Clementi; Anders P Hakansson
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

10.  The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents.

Authors:  Laura R Marks; Emily A Clementi; Anders P Hakansson
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.